Skip to main content
. 2023 Jan 19;72(4):787–798. doi: 10.1136/gutjnl-2020-320633

Figure 6.

Figure 6

Treatments targeting immune activation. Solid lines: a demonstrated benefit. Dashed lines: potential benefit, but not formally tested. 5-HT3, Serotonin 3 receptor; Eo, eosinophil; H1R, histamine 1 receptor; MC, mast cell; PPI, proton-pump inhibitor.